GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

Clinical trial NCT04387201 · COMPLETED

Trial details

NCT number: NCT04387201
Sponsor: The University of Texas Health Science Center, Houston
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Glucose Intolerance Overweight and Obesity Drug Effect Adiposity

Start date: 2020-05-15
Primary completion: 2023-10-06
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.